Literature DB >> 15749118

HCV associated glomerulopathy in Egyptian patients: clinicopathological analysis.

Alaa Sabry1, Amgd E-Agroudy, Hussein Sheashaa, Amr El-Husseini, Nohir Mohamed Taha, Mahmoud Elbaz, Mohamed Sobh.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) infection in Egypt has reached an epidemic proportion and is associated with many extra hepatic manifestations; Glomerulonephritis (GN) is one of the most consequences of HCV infection often resulting in end stage renal disease in some cases. Detection of viral genome or particles within the kidney biopsies from HCV-infected patients has proven to be difficult. Histological characterization of renal lesions still represents a major challenge. The aim of our work was to describe the histological pattern of HCV-associated nephropathy.
METHODS: Fifty Patients--out of 233--presented to Mansoura Urology and Nephrology clinic with manifestations of glomerular disease were screened for HCV antibodies by a 3rd generation ELISA test. Those tested positive for HCV antibodies were confirmed by PCR for HCV-RNA and subjected to more detailed clinical, biochemical and histological study. Kidney biopsies and in appropriate cases liver biopsies were examined by LM and electron microscopy (EM).
RESULTS: Histological study of renal biopsies revealed membranoproliferative (MPGN) type 1 to be the most common lesion encountered (54%), followed by focal segmental glomerulosclerosis (FSGS) (24%), mesangioproliferative GN (18%), membranous nephropathy (MN) (4%) in that order. EM examinations of renal biopsies were successful in identifying HCV like particles in frozen renal tissue.
CONCLUSION: HCV-associated glomerulopathy is a distinct category of glomerulonephritis. Results of LM showed some peculiar features. In addition, we were successful in location and detection of HCV particles in renal tissues by EM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15749118     DOI: 10.1016/j.virol.2005.01.013

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Hepatitis C virus and its renal manifestations: a review and update.

Authors:  Nyan Latt; Nada Alachkar; Ahmet Gurakar
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-07

2.  Microalbuminuria in hepatitis C-genotype 4: effect of pegylated interferon and ribavirin.

Authors:  Moutaz Derbala; Fatma-M Shebl; Awad Rashid; Aliaa Amer; Abdulbari Bener
Journal:  World J Gastroenterol       Date:  2010-03-14       Impact factor: 5.742

3.  Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

Authors:  Roberto Minutolo; Alessio Aghemo; Antonio Chirianni; Fabrizio Fabrizi; Loreto Gesualdo; Edoardo G Giannini; Paolo Maggi; Vincenzo Montinaro; Ernesto Paoletti; Marcello Persico; Francesco Perticone; Salvatore Petta; Massimo Puoti; Giovanni Raimondo; Maria Rendina; Anna Linda Zignego
Journal:  Infection       Date:  2018-09-25       Impact factor: 3.553

4.  Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

Authors:  Roberto Minutolo; Alessio Aghemo; Antonio Chirianni; Fabrizio Fabrizi; Loreto Gesualdo; Edoardo G Giannini; Paolo Maggi; Vincenzo Montinaro; Ernesto Paoletti; Marcello Persico; Francesco Perticone; Salvatore Petta; Massimo Puoti; Giovanni Raimondo; Maria Rendina; Anna Linda Zignego
Journal:  J Nephrol       Date:  2018-09-25       Impact factor: 3.902

5.  Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

Authors:  Roberto Minutolo; Alessio Aghemo; Antonio Chirianni; Fabrizio Fabrizi; Loreto Gesualdo; Edoardo G Giannini; Paolo Maggi; Vincenzo Montinaro; Ernesto Paoletti; Marcello Persico; Francesco Perticone; Salvatore Petta; Massimo Puoti; Giovanni Raimondo; Maria Rendina; Anna Linda Zignego
Journal:  Intern Emerg Med       Date:  2018-09-25       Impact factor: 3.397

Review 6.  Hepatitis C virus associated glomerulopathies.

Authors:  Abdullah Ozkok; Alaattin Yildiz
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

Review 7.  Hepatitis C virus viremic rate in the Middle East and North Africa: Systematic synthesis, meta-analyses, and meta-regressions.

Authors:  Manale Harfouche; Hiam Chemaitelly; Silva P Kouyoumjian; Sarwat Mahmud; Karima Chaabna; Zaina Al-Kanaani; Laith J Abu-Raddad
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

Review 8.  Hepatitis Virus C-associated Nephropathy: A Review and Update.

Authors:  Elmukhtar Habas; Khalifa L Farfar; Nada Errayes; Ala M Habas; Mehdi Errayes; Gamal Alfitori; Amnna Rayani; Mohamed Elgara; Aisha H Al Adab; Abdulnaser Elzouki
Journal:  Cureus       Date:  2022-07-27

9.  Socio-demographic and clinical features of Irish iatrogenic hepatitis C patients: a cross-sectional survey.

Authors:  Olivia McKenna; Caitriona Cunningham; Catherine Blake
Journal:  BMC Public Health       Date:  2009-09-07       Impact factor: 3.295

10.  Chapter 9: Infection-related glomerulonephritis.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.